Cognition Therapeutics, Inc.
CGTX
$1.01
-$0.03-2.89%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 10.46M | 10.32M | 10.61M | 10.66M | 11.13M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 36.60M | 42.84M | 47.80M | 44.85M | 52.94M |
| Operating Income | -36.60M | -42.84M | -47.80M | -44.85M | -52.94M |
| Income Before Tax | -16.78M | -19.58M | -23.49M | -27.99M | -32.99M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -16.78 | -19.58 | -23.49 | -27.99 | -32.99 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.78M | -19.58M | -23.49M | -27.99M | -32.99M |
| EBIT | -36.60M | -42.84M | -47.80M | -44.85M | -52.94M |
| EBITDA | -36.55M | -42.79M | -47.73M | -44.77M | -52.84M |
| EPS Basic | -0.20 | -0.26 | -0.34 | -0.48 | -0.66 |
| Normalized Basic EPS | -0.12 | -0.16 | -0.21 | -0.30 | -0.42 |
| EPS Diluted | -0.20 | -0.26 | -0.35 | -0.49 | -0.68 |
| Normalized Diluted EPS | -0.12 | -0.16 | -0.21 | -0.30 | -0.42 |
| Average Basic Shares Outstanding | 346.37M | 319.44M | 292.07M | 248.15M | 210.62M |
| Average Diluted Shares Outstanding | 346.37M | 319.44M | 292.07M | 248.15M | 210.62M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |